Stock FUSN FUSN PHAR
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-17 EDT 		5-day change 1st Jan Change
21.51 USD +0.23% Intraday chart for FUSN PHAR +0.14% +123.83%
05-09 Fusion Pharmaceuticals Inc. Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer CI
05-07 Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
  1. Stock Market
  2. Equities
  3. FUSN Stock
  4. Charts FUSN PHAR
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW